Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROSHARES TRUST (ZBIO) Current Leases: 2023-2025

Historic Current Leases for Zenas BioPharma (ZBIO) over the last 1 years, with Sep 2025 value amounting to $618,000.

  • Zenas BioPharma's Current Leases rose 60.94% to $618,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $618,000, marking a year-over-year increase of 60.94%. This contributed to the annual value of $785,000 for FY2024, which is 41.19% up from last year.
  • As of Q3 2025, Zenas BioPharma's Current Leases stood at $618,000, which was down 22.07% from $793,000 recorded in Q2 2025.
  • Zenas BioPharma's 5-year Current Leases high stood at $908,000 for Q1 2025, and its period low was $384,000 during Q3 2024.
  • In the last 3 years, Zenas BioPharma's Current Leases had a median value of $701,500 in 2024 and averaged $674,000.
  • Data for Zenas BioPharma's Current Leases shows a peak YoY spiked of 60.94% (in 2025) over the last 5 years.
  • Zenas BioPharma's Current Leases (Quarterly) stood at $556,000 in 2023, then skyrocketed by 41.19% to $785,000 in 2024, then surged by 60.94% to $618,000 in 2025.
  • Its Current Leases was $618,000 in Q3 2025, compared to $793,000 in Q2 2025 and $908,000 in Q1 2025.